Clinical Trials
Showing trials with last updates posted in 2025.
20283
Participants
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-04-11
Completion:
2026-10-31
Conditions
Atrial Fibrillation
Interventions
DRUG
No Results Yet
60
Participants
(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-05-09
Completion:
2027-02-28
Conditions
Head and Neck Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell Carcinoma
Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck
Interventions
BIOLOGICAL
DRUG
PROCEDURE
OTHER
No Results Yet
29
Participants
Study 1: Social Engage Coaching R61 Phase
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-06-13
Completion:
2025-09-30
Conditions
Social Isolation
Loneliness
Suicide Ideation
Quality of Life
Interventions
BEHAVIORAL
No Results Yet
70
Participants
Peri-urethral Bulk Agent Injection of Bulkamid®
Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2022-10-01
Completion:
2022-11-30
Conditions
Urinary Incontinence
Interventions
PROCEDURE
No Results Yet
29
Participants
Improving Physical Function in Older Adults Using an Anti-inflammation Drug: The RIGHT Study
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-08-01
Completion:
2026-02-28
Conditions
Inflammation
Frailty
Interventions
DRUG
No Results Yet
360
Participants
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-05-09
Completion:
2026-10-31
Conditions
Focal Onset Seizures
Interventions
DRUG
No Results Yet
1135
Participants
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-03-23
Completion:
2029-09-18
Conditions
Bladder Cancer
Interventions
DRUG
BIOLOGICAL
No Results Yet
342
Participants
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-05-31
Completion:
2032-04-15
Conditions
Heart Failure
Left Ventricular Systolic Dysfunction
Interventions
DRUG
No Results Yet
15000
Participants
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-02-15
Completion:
2026-11-11
Conditions
Ischemic Stroke; Ischemic Attack, Transient
Interventions
DRUG
No Results Yet
47
Participants
The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-03-16
Completion:
2025-01-22
Conditions
Atopic Dermatitis
Interventions
DRUG
90
Participants
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-12-14
Completion:
2026-04-22
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
160
Participants
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-02-14
Completion:
2027-04-30
Conditions
Primary Generalized Tonic-Clonic Seizures
Interventions
DRUG
No Results Yet
56
Participants
A Web-Based Dyadic Intervention for Colorectal Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-05-01
Completion:
2026-10-01
Conditions
Colorectal Carcinoma
Interventions
OTHER
No Results Yet
96
Participants
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-01-16
Completion:
2025-09-30
Conditions
Transthyretin-Mediated Amyloidosis
Interventions
DRUG
No Results Yet
551
Participants
A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice
Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2023-02-27
Completion:
2030-12-30
Conditions
Systemic Lupus Erythematosus
Interventions
OTHER
No Results Yet
1174
Participants
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-11-28
Completion:
2027-09-20
Conditions
Breast Cancer
Interventions
DRUG
No Results Yet
500
Participants
Vascular Lab Resource (VLR) Biorepository
Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2019-11-14
Completion:
2030-12-31
Conditions
Cardiovascular Diseases
Metabolic Disease
Peripheral Artery Disease
Carotid Disease
Aneurysmal Disease
Venous Disease
Thrombosis
Lymphedema
Lipedema
Non-Atherosclerotic Chronic Arterial Occlusive Disease
Vasculitis
Fibromuscular Dysplasia
Arterial Dissection
May-Thurner Syndrome
Thoracic Outlet Syndrome
Vasospasm
No Results Yet
22
Participants
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-06-15
Completion:
2028-06-15
Conditions
LCA5
Interventions
BIOLOGICAL
No Results Yet
62
Participants
Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes
Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2023-05-03
Completion:
2025-01-28
Conditions
Type 1 Diabetes
Hypoglycemia
Interventions
OTHER
No Results Yet
360
Participants
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-11-18
Completion:
2025-12-31
Conditions
Focal Onset Seizures
Interventions
DRUG
No Results Yet
15
Participants
A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-01-23
Completion:
2024-05-22
Conditions
Multiple Myeloma
Interventions
DRUG
28
Participants
A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function.
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-10-31
Completion:
2025-10-16
Conditions
Hepatic Impairment
Interventions
DRUG
No Results Yet
2904
Participants
Safety of Ibuprofen After Major Orthopaedic Surgeries
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-04-17
Completion:
2025-08-19
Conditions
Safety Issues
Analgesia
Analgesic Adverse Reaction
Postoperative Pain
Postoperative Complications
Knee Arthropathy
Pain, Acute
Hip Arthropathy
Interventions
DRUG
No Results Yet
60
Participants
Effect of Acute Bout of Exercise on Levels of PAHSA
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2021-05-01
Completion:
2025-12-12
Conditions
Insulin Sensitivity
Interventions
OTHER
No Results Yet
614
Participants
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-03-29
Completion:
2026-02-13
Conditions
Relapsed or Refractory Multiple Myeloma
Interventions
DRUG
No Results Yet
11
Participants
A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy
Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2024-01-17
Completion:
2026-01-21
Conditions
Hemophilia B
Interventions
OTHER
No Results Yet
17
Participants
A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-01-25
Completion:
2025-11-20
Conditions
Plaque Psoriasis
Interventions
DRUG
No Results Yet
700
Participants
Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors
Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2022-10-24
Completion:
2027-10-31
Conditions
Miscarriage
Early Pregnancy Loss
No Results Yet
15
Participants
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-01-12
Completion:
2024-06-04
Conditions
Multiple Myeloma
Interventions
DRUG
1590
Participants
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-10-25
Completion:
2031-04-30
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
148
Participants
Autologous BMA vs Saline and LAM + LP-PRP vs Saline Evaluations in Knee OA
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2025-01-01
Completion:
2026-06-30
Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL
OTHER
No Results Yet
69
Participants
Study to Assess SLN124 in Patients With Polycythemia Vera
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-01-26
Completion:
2026-09-30
Conditions
Polycythemia Vera
Interventions
DRUG
No Results Yet
520
Participants
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-11-11
Completion:
2027-08-17
Conditions
Carcinoma, Non-small-Cell Lung
Interventions
DRUG
No Results Yet
10800
Participants
Evaluation of the Be Vape Free Curriculum of the Tobacco Prevention Toolkit
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-10-19
Completion:
2026-06-01
Conditions
E-cigarette Use
Interventions
BEHAVIORAL
No Results Yet
708
Participants
DIStal Versus COnventional Radial Access for COMPLEX Large-bore Percutaneous Coronary Intervention
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-08-31
Completion:
2026-06-01
Conditions
Vascular Access Site Occlusion
Interventions
PROCEDURE
No Results Yet
57
Participants
A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-12-13
Completion:
2026-06-09
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG
No Results Yet
30
Participants
Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-09-30
Completion:
2026-06-30
Conditions
Stroke
Interventions
DEVICE
No Results Yet
100
Participants
Observational Study of Ketamine Infusions for the Treatment of Chronic Pain
Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2022-06-01
Completion:
2026-12-31
Conditions
Chronic Pain
Interventions
DRUG
No Results Yet
92
Participants
A Care Empowerment Program Using Virtual Reality for Family Caregivers of People With Dementia
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-08-01
Completion:
2023-07-01
Conditions
Dementia Family Caregiver
Interventions
OTHER
No Results Yet
24
Participants
Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-07-11
Completion:
2025-12-12
Conditions
Furmonertinib
EGFR-mutation
NSCLC
Brain Metastases
Interventions
DRUG
No Results Yet
Showing 40 trials per page